Spotlight on: Cyclic peptides

What are cyclic peptides?

Cyclic peptides are a diverse group of bioactive compounds that are present in almost all living organisms, from plants, bacteria, and animals. They are a distinct category of peptide compounds in which the peptide chain forms a continuous loop via covalent bonds, differentiating them from their linear peptide siblings. ​

​Their great diversity means their therapeutic uses are wide-ranging: from antibiotics, antifungals, antiparasitics, and immune modulators to anti-inflammatory agents. In pharmaceutical therapies, cyclic peptides are an exciting and increasingly important class of molecules, offering a unique blend of properties that bridge the gap between small molecules and biologics. Because of their shape, they exhibit conformational stability and protection against enzymatic breakdown, giving them a unique ability to serve distinctive biological functions compared to linear peptides. ​

Why are cyclic peptides both challenging and interesting? 

Cyclic peptides pose several analytical challenges in drug development and characterization due to their multiple conformations. Additionally, their many intramolecular interactions, hydrogen bonding, and steric effects can obscure functional groups, complicating spectroscopic analyses such as NMR. ​

​While LC-MS analysis can be complex, it offers the benefit of separating cyclic peptides from impurities, degradation products, and uncyclized precursors. When performing bioanalysis experiments, this is especially useful for analyzing synthetic mixtures or biological samples such as plasma or tissue extracts. Sensitive mass spectrometric detection enables the detection of low-level analytes and distinguishes between closely related analogs, including isomers and modified peptides.

How are cyclic peptides impacting the world?

Cyclic peptides are unlocking undruggable targets. Many diseases are driven by protein-protein interactions, which are notoriously difficult to target with traditional small molecules. Cyclic peptides can bind tightly and selectively to these interfaces, making them ideal for modulating protein-protein interactions. Some examples of where they are currently being used include organ transplantation (kidney, liver, and heart) to prevent rejection, autoimmune diseases such as rheumatoid arthritis, and in the treatment of psoriasis.

​There are over 40 cyclic peptides currently approved and used as clinical therapeutics, many of which are natural peptides. In the last few decades, an emerging trend in drug discovery has been the optimization of naturally isolated cyclic peptides to improve aspects like stability, potency, and pharmacokinetic properties via chemical synthesis, computational, and in vitro methods – allowing for a great variety of drug delivery methods.

How does SCIEX help overcome key challenges?

Along with the emerging interest in advancing cyclic peptide therapeutics, there is a corresponding drive to develop highly robust and sensitive quantitative methods. Current bioanalytical methods lack the sensitivity necessary to reliably quantify cyclic peptides. For LC-MS-based methods, high baseline interference in single MS mode and resistance to CID in MS/MS mode, due to the tertiary structure, affect overall sensitivity.​

The SCIEX 7500+ system is a great option for cyclic peptide analysis because it offers exceptional sensitivity for low-level analytes and continuous robust performance, even in complex matrices. And when high resolution is needed to separate closely eluting analytes with similar masses or background noise, the SCIEX 7600+ system is an excellent choice. Both systems are powered by SCIEX OS software, which is streamlined for data acquisition, processing, and management – all in a 21 CFR Part 11 compliance-ready environment.

Key benefits of cyclic peptides

  • Legumes produce cyclic peptides to defend against pathogens, whereas marine animals, like sponges and cone snails, produce peptides that act as toxins for predation or defense
  • Many cyclic peptides produced by bacteria (like subtilin from Bacillus subtilis) are also used as a defense mechanism to inhibit other microorganisms​
  • Meanwhile, fungal cyclic peptides are a key source for peptides with immunomodulatory properties​
  • Outside of drug molecules, cyclic peptides are used in biosensor development – like, tumor marker detection for early cancer diagnosis​
  • They are also used in materials science for tissue engineering, or they can be used to encapsulate other drug molecules enabling controlled release and efficacy​

Explore more below:

Low-pg/mL quantification of cyclic peptides in rat plasma using microflow LC

This technical note describes the enhancement of lower limits of quantification (LLOQs) for cyclic peptides by using a microflow trap-and-elute method.

Explore more

Improved LC-MRM Sensitivity for Cyclic Peptide Quantification on Natriuretic Peptide Family

See how outstanding reproducibility, accuracy, and linearity was achieved, proving the workflow robustness in parallel with the superior sensitivity.

Learn more

Sensitive LC-MRM HR approach for cyclic peptide quantitation inhuman plasma

See how a lower limit of quantitation (LLOQ) of 0.05 ng/mL was achieved in extracted plasma samples.

Explore more

A simple and highly sensitive solution for the quantification of cyclic peptides

Low-level quantification was achieved with outstanding accuracy, precision and linearity.

Read more

Solution

Ultimate quantitation

Benefits:

  • Reliably quantify at low limits
  • Future-proof your methods
ExionLC AE system

Reproducibility, reliability and carryover performance to match your quantitative workflows. Dependability you can count on, from injection to injection and batch after batch.

Learn more
SCIEX 7500+ system

A new standard for instrument resilience and robustness. Engineered to maintain our highest sensitivity for up to twice as long in complex matrices.

Learn more
SCIEX OS software

Unleash the analytical power of the next-generation software platform for data acquisition and processing.

Learn more
Service

Keep your instruments performing at their peak, with multiple options for response time, repair coverage and maintenance.

Learn more

In case you missed it…

Catch up on past months topics

            Each month, the Spotlight on series will highlight a different challenging molecule or class of compounds as well as related LC-MS solutions, unmatched in terms of sensitivity and accuracy, that will help customers meet today’s and future needs.

Cyclic Peptides

Cyclic peptides are stable, bioactive molecules that resist enzymatic breakdown and can target protein–protein interactions, making them valuable for treating conditions such as autoimmune disease, transplant rejection, and inflammation. While these complex molecules are challenging to analyze, advanced LC MS platforms like the SCIEX 7500+ and 7600+ systems deliver the sensitivity and resolution needed to advance their therapeutic potential.

Learn more
SCIEX OS software

SCIEX OS software streamlines instrument control and automates data processing to simplify lab workflows and support fast, informed decisions. It serves both new and experienced users by maintaining compliance through audit trails and role-based access, while automating routine tasks so scientists can focus on discovery. Designed for all the latest SCIEX mass spectrometry systems and now enhanced with Windows 11 support to meet IT security policies and reduce cybersecurity risks.

Learn more
GLP-1

GLP-1 is a multifaceted hormone that regulates blood glucose, influences appetite and weight, and provides cardiovascular benefits. Continued research and development of GLP-1-based therapies promise to advance and expand potential uses. The sensitivity, specificity, and versatility of LC-MS plays a major role in advancing GLP-1 research with new insights.

Learn more
Bile acids

Bile acid biochemistry was once poorly understood, but growing interest in the gut-brain axis and microbiome has sparked new research. LC-MS technology is advancing knowledge of bile acids' roles and potential as therapeutic targets and biomarkers.

Learn more
Fentanyl

Fentanyl has garnered significant attention in recent years due to its critical role in both medical and illicit contexts. As a compound, it offers unparalleled pain relief, but also contributes to an alarming rate of opioid-related overdoses. Studying fentanyl is essential to developing effective therapeutic applications, understanding its pharmacokinetics, and addressing the public health crisis it poses. LC-MS/MS has emerged as a transformative technology in advancing fentanyl research, providing precise and comprehensive analytical capabilities.

Learn more
Oligonucleotides

Oligonucleotides are pivotal in genetic research, diagnostics, and therapeutics. Explore the intricacies of these molecules and how LC-MS technologies are propelling their research to new heights, enabling scientists to achieve exceptional levels of accuracy in oligonucleotide characterization and quantitation.

Learn more
Lipid mediators

The third topic in the Spotlight on series explores lipid mediators, a highly potent family of signaling molecules, perhaps best known for their role in inflammation. Due to their potent biological activities and often transient existence, precise and sensitive analytical techniques are essential for their study.

Learn more
Nitrosamines

Get a deeper understanding of what makes nitrosamines a concern, what is being done to understand and test for nitrosamines, and how SCIEX LC-MS solutions can help give you confidence in your quantitation needs: for today and tomorrow.

Learn more
PFAS

PFAS are an extensive, complex group of manufactured chemicals that are ubiquitous throughout the environment, accumulate from many different sources and whose consumption is currently unavoidable. With accumulating toxicity a rising concern, sensitive and resilient analysis is key to understanding exposure risks. LC-MS is considered the gold standard for detecting and quantifying PFAS molecules and has become the “defacto” methodology for analysis.

Learn more
Targeted protein degraders

The second topic in the Spotlight on series covers targeted protein degraders (TPDs), a cutting-edge approach in the field of drug development. By leveraging an event-driven mechanism that degrades unwanted or harmful proteins, rather than the traditional occupancy-driven approach, TPDs offer several significant therapeutic benefits that make them particularly promising for treating challenging conditions.

Learn more